HOOKIPA Pharma Inc. announced On April 7, 2023, Michael A. Kelly, a member of the Board, notified the Company of his resignation from the Board, including the Audit Committee of the Board (the “Audit Committee”), on which he serves as the Chair and a member and the Compensation Committee of the Board on which he serves as a member, effective April 7, 2023. Mr. Kelly's decision to resign from the Board is not due to any disagreement with the Company's operations, policies or practices. On April 7, 2023, effective upon the resignation of Mr. Kelly, the Board appointed Terry Coelho as the Chair of the Audit Committee to fill the newly created vacancy resulting from Mr. Kelly's resignation, until a successor is elected and qualified, or until her earlier death, resignation or removal, or until otherwise determine by the Board.

The Board has deemed Ms. Coelho is an “audit committee financial expert” as defined in Item 407(d)(5)(ii) and (iii) of Regulation S-K.